TCM Ltd.

BSE: 524156 SECTOR: Chemicals  6356   10   0

34.45
+0.07 (0.20%)
BSE: Today, 10:30 AM

Price Summary

Today's High

₹ 34.45

Today's Low

₹ 33.5

52 Week High

₹ 58.05

52 Week Low

₹ 0

FinStar is Suspended!

FinStar can not be assigned to this company due to its dicey outlook and insufficient data. We will update the FinStar for this company as soon as the data is updated from its end.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

25.76 Cr.

Enterprise Value

31.52 Cr.

No. of Shares

0.75 Cr.

P/E

0

P/B

0.73

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  47.51

CASH

0.27 Cr.

DEBT

6.03 Cr.

Promoter Holding

47.25 %

EPS (TTM)

₹  -4.61

Sales Growth

-18.67%

ROE

-61.67 %

ROCE

-17.64%

Profit Growth

-251.07 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-18.67%
3 Year105.88%
5 Year∞%

Profit Growth

1 Year-251.07%
3 Year-24.26%
5 Year-183.99%

ROE%

1 Year-61.67%
3 Year-20.56%
5 Year-12.33%

ROCE %

1 Year-17.64%
3 Year-5.88%
5 Year-3.53%

Debt/Equity

0.1881

Price to Cash Flow

-6.89

Interest Cover Ratio

-103.514084507042

CFO/PAT (5 Yr. Avg.)

0

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2023 47.25 0
Dec 2022 47.25 0
Sep 2022 47.25 0
Jun 2022 47.25 0
Mar 2022 36.8 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 105.880783763576% for the Past 3 years.
  • The company has an efficient Cash Conversion Cycle of -136.063498553407 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 4.46744756963269.

 Limitations

  • The company has shown a poor profit growth of -24.2595609660022% for the Past 3 years.
  • Company has a poor ROE of -20.5568252649075% over the past 3 years.
  • Company has a poor ROCE of -5.8793413089824% over the past 3 years
  • Company has low Interest coverage ratio of -103.514084507042.
  • Company has high debtor days of 281.64036508809.
  • Company has negative cash flow from operations of -3.7371.
  • The company has a low EBITDA margin of -73.132473611904% over the past 5 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022
Net Sales 0.11 1.36 0.55 1.1 0.79
Total Expenditure 0.65 3.03 1.58 1.37 1.83
Operating Profit -0.54 -1.67 -1.03 -0.28 -1.05
Other Income 0.04 0.51 0.01 0.21 0.05
Interest 0 0 0 0 0
Depreciation 0.01 0.01 0.01 0.15 0.01
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.52 -1.18 -1.04 -0.22 -1.01
Tax 0 0 0 0 0
Profit After Tax -0.52 -1.18 -1.04 -0.22 -1.01
Adjusted EPS (Rs) -0.95 -2.16 -1.39 -0.3 -1.35

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Net Sales 0 0.4 0.92 4.25 3.46
Total Expenditure 0.36 1.26 1.67 4.22 5.77
Operating Profit -0.36 -0.86 -0.75 0.03 -2.31
Other Income 0.23 0.04 1.15 1.23 0.88
Interest 0 0.12 0.01 0.01 0.01
Depreciation 0 0 0.01 0.02 0.04
Exceptional Items -0.62 0 0 0 0
Profit Before Tax -0.75 -0.95 0.39 1.23 -1.48
Tax 0 0 0 0.25 0
Net Profit -0.75 -0.95 0.39 0.98 -1.48
Adjusted EPS (Rs.) -1.37 -1.74 0.71 1.8 -2.72

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Equity and Liabilities
Share Capital 3.4 3.4 3.4 3.4 3.4
Total Reserves 30.33 29.02 29.16 30.14 28.65
Borrowings 0 0 0 0 0.07
Other N/C liabilities 19.68 19.68 19.68 19.68 19.68
Current liabilities 11.44 17.05 13.21 15.29 16.08
Total Liabilities 64.85 69.15 65.44 68.51 67.88
Assets
Net Block 58.01 58.01 58.01 58.42 54.7
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0.8 0.44 0.19 0.19 0.03
Loans & Advances 1.94 1.97 2.1 3.98 5.41
Other N/C Assets 0 0 0 0 0
Current Assets 4.09 8.73 5.14 5.92 7.75
Total Assets 64.85 69.15 65.44 68.51 67.88
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022
Profit from operations -0.75 -0.95 0.39 0.98 -1.48
Adjustment 0.1 0 0.01 0.2 0.04
Changes in Assets & Liabilities -3.74 -0.69 -0.96 -0.91 -2.29
Tax Paid 0 0 0 0 0
Operating Cash Flow -4.39 -1.63 -0.56 -0.11 -3.74
Investing Cash Flow 3.98 -0.01 -0.01 -0.04 3.85
Financing Cash Flow 0.15 5.32 -3.14 0.18 0.11
Net Cash Flow -0.25 3.68 -3.7 0.03 0.22

Corporate Actions

Investors Details

PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Promoters 36.80 47.25 47.25 47.25 47.25
joseph varghese 23.22 23.22 23.22 21.06 21.06
george varghese 13.55 13.55 13.55 13.55 13.55
rani jose 0.01 0.01 0.01 0.01 -
rani jose - - - - -
rani george - - - - 0.01
PARTICULARS Mar 2022% Jun 2022% Sep 2022% Dec 2022% Mar 2023%
Investors 63.20 52.75 52.75 52.75 52.75
life insurance cor... - - 23.72 - 23.72
lic 23.72 23.72 - - -
life insurance cor... - - - - -
joseph abraham - - - 10.76 -
joseph abraham 10.76 10.76 10.76 - 10.76
venkateswara rao c... - - 5.17 5.17 -
venlateswara rao - - - - 5.17
venkateswara rao 5.17 - - - -
venkateswara rao ... - 5.17 - - -
ankush vinod pitale - - - 1.81 1.81
the new india assu... - - 1.46 1.46 1.46
the new india assu... 1.46 - - - -
the new india assu... - - - - -
the new india assu... - 1.46 - - -
the new india assu... - - - - -
amit jasani financ... 1.18 - - - -
amit jasani financ... - - - - 1.18
amit jasani financ... - 1.09 - - -
amit jasani financ... - - 1.09 - -
amit jasani financ... - - - - -

Annual Reports

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Currently we do not have any Presentation and Concall related to this company.Report us

Company News

TCM informs about proceedings of EGM 25 Mar 2023, 2:44PM TCM informs about award of order20 Mar 2023, 2:50PM TCM bags order from ANERT20 Mar 2023, 2:29PM TCM bags order from ANERT3 Mar 2023, 11:40AM TCM informs about book closure 2 Mar 2023, 2:59PM Tcm informs about EGM2 Mar 2023, 2:56PM TCM informs about disclosure10 Feb 2023, 5:19PM TCM - Quaterly Results8 Feb 2023, 12:58PM TCM - Quaterly Results8 Feb 2023, 12:58PM TCM - Quaterly Results8 Feb 2023, 12:58PM TCM receives order from Government of Kerala for three sites9 Jan 2023, 2:42PM TCM informs about incorporation of a wholly owned subsidiary13 Dec 2022, 4:35PM TCM incorporates wholly owned subsidiary company13 Dec 2022, 3:45PM TCM gets nod to incorporate new wholly owned subsidiary 7 Dec 2022, 11:38AM TCM - Quaterly Results8 Nov 2022, 2:50PM TCM - Quaterly Results8 Nov 2022, 2:50PM TCM informs about compliance certificate14 Oct 2022, 5:10PM TCM buys additional stake in iSpark Learning Solutions12 Sep 2022, 2:23PM TCM informs about incorporation of wholly owned subsidiary company19 Aug 2022, 3:48PM TCM incorporates wholly owned subsidiary company19 Aug 2022, 12:59PM TCM informs about proceedings of EGM 30 Jul 2022, 10:49AM TCM to raise investment in iSpark Learning Solutions 21 Jul 2022, 5:35PM TCM informs about newspaper publication11 Jul 2022, 4:28PM TCM informs about EGM notice6 Jul 2022, 10:11AM TCM informs about outcome of board meeting 2 Jul 2022, 4:49PM TCM informs about book closure 2 Jul 2022, 1:52PM TCM gets nod to develop Kalamassery land27 Jun 2022, 10:16AM TCM informs about outcome of board meeting25 Jun 2022, 3:10PM TCM informs about non-applicability of large corporate entity28 Apr 2022, 11:51AM TCM informs about board meeting18 Apr 2022, 11:48AM TCM - Quaterly Results12 Feb 2022, 1:23PM TCM informs about outcome of board meeting19 Jan 2022, 12:47PM TCM informs about board meeting 4 Oct 2021, 1:28PM TCM informs about book closure19 Aug 2021, 2:34PM TCM informs about outcome of board meeting19 Aug 2021, 1:48PM TCM informs about newspaper clippings 17 Aug 2021, 12:56PM TCM informs about closure of trading window1 Jul 2021, 11:49AM TCM informs about clarification on price movement4 May 2021, 12:40PM TCM informs about non-applicability of large corporate entity29 Apr 2021, 3:40PM TCM informs about consolidated cash flow statement11 Dec 2020, 10:54AM TCM informs about press release19 Nov 2020, 4:26PM TCM rolls out first batch of COVID 19 RT-qPCR Test Kits 22 Oct 2020, 1:36PM TCM obtains loan license from Central Drugs Standard Control Organisation21 Sep 2020, 4:33PM TCM incorporates wholly owned subsidiary company16 Jul 2020, 10:52AM TCM informs about board meeting22 Jun 2020, 10:26AM TCM enters into non-exclusive licensing agreement with FITT15 Jun 2020, 9:18AM

TCM Stock Price Analysis and Quick Research Report. Is TCM an attractive stock to invest in?

 

Stock investing requires careful analysis of financial data to find out the company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement. This can be time-consuming and cumbersome. An easier way to find out about a company's performance is to look at its financial ratios, which can help to make sense of the overwhelming amount of information that can be found in a company's financial statements.

Here are the few indispensable tools that should be a part of every investor’s research process.

  • PE ratio: - Price to Earnings' ratio, which indicates for every rupee of earnings how much an investor is willing to pay for a share. A general rule of thumb is that shares trading at a LOW P/E are undervalued (it depends on other factors too). TCM has a PE ratio of -7.46045179350303 which is low and comparatively undervalued .

  • Return on Assets (ROA): - Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. TCM has ROA of -2.17636138069387 % which is a bad sign for future performance. (higher values are always desirable)

  • Current ratio: - The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. TCM has a Current ratio of 0.481822365393465 .

  • Return on equity: - ROE measures the ability of a firm to generate profits from its shareholders investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. TCM has a ROE of -61.6704757947226 % .(higher is better)

  • Debt to equity ratio: - It is a good metric to check out the capital structure along with its performance. TCM has a D/E ratio of 0.1881 which means that the company has low proportion of debt in its capital.

  • Inventory turnover ratio: - Inventory Turnover ratio is an activity ratio and is a tool to evaluate the liquidity of a company's inventory. It measures how many times a company has sold and replaced its inventory during a certain period of time. TCM has an Inventory turnover ratio of 1.46197766875317 which shows that the management is inefficient in relation to its Inventory and working capital management.

  • Sales growth: - TCM has reported revenue growth of -18.6658823529412 % which is poor in relation to its growth and performance.

  • Operating Margin: - This will tell you about the operational efficiency of the company. The operating margin of TCM for the current financial year is -66.9569242340961 %.

  • Dividend Yield: - It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for TCM is Rs 0 and the yield is 0 %.

Brief about TCM

X